Evista is an oral medication that has revolutionized the way women manage their health. Developed by Eli Lilly and Company, Evista is a selective estrogen receptor modulator (SERM) that helps reduce the risk of certain cancers, including breast cancer, while also providing other benefits to women's health. In this article, we will discuss the benefits of Evista and how it is revolutionizing women's health.
Evista is a SERM, which means that it works by selectively blocking the action of estrogen in certain parts of the body. In the case of Evista, it works by blocking the action of estrogen in the bones. This helps to reduce the risk of osteoporosis, a condition where bones become weak and brittle due to a loss of calcium. By blocking the action of estrogen in the bones, Evista helps to keep bones strong and healthy.
One of the most important benefits of Evista is its ability to reduce the risk of breast cancer. Studies have shown that Evista can reduce the risk of breast cancer by up to 50%. This is because Evista helps to block the action of estrogen in the breast tissue, which can help to reduce the risk of estrogen-dependent breast cancer.
As mentioned above, Evista helps to reduce the risk of osteoporosis by blocking the action of estrogen in the bones. This helps to keep bones strong and healthy, reducing the risk of fractures and other bone-related issues. In addition, Evista can also help to reduce the risk of bone loss in postmenopausal women, making it an important tool in helping women maintain their bone health.
In addition to reducing the risk of breast cancer and osteoporosis, Evista can also provide other benefits to women's health. For example, Evista can help reduce the risk of coronary heart disease, as well as reduce the risk of blood clots. It can also help to reduce the risk of stroke and can help to reduce the risk of endometrial cancer.
Evista is an important medication that is revolutionizing women's health. It helps to reduce the risk of breast cancer, osteoporosis, coronary heart disease, blood clots, stroke, and endometrial cancer. By blocking the action of estrogen in certain parts of the body, Evista helps to keep bones strong and healthy, while also reducing the risk of other health issues. For these reasons, Evista is an important tool for women's health and is revolutionizing the way women manage their health.
1.
NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.
2.
In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.
3.
FDA Expands Durvalumab Label to Operable Lung Cancer
4.
New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations
5.
There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.
1.
The Architect's Dilemma: Remodeling the Tumor Microenvironment for a New Era of Cancer Immunotherapy
2.
Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care
3.
Unveiling the Hidden Benefits of Lymphedema Treatment
4.
IGF2BP1 in Blood Disorders: Therapeutic Potential and Comprehensive Functional Insights
5.
Florinef: Understanding Its Uses and Side Effects
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
3.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
4.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation